Heptaplatin (SunPla)

General information

Class/mechanism: A second-generation platinum agent with antineoplastic activity.
Route: IV
Extravasation: no information

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias or the prescribing information.

Diseases for which it is used

• Gastric cancer

Also known as

• Code name: SKI-2053R
• Brand name: SunPla